Flecchia, Clémence
Auclin, Edouard
Alouani, Emily
Mercier, Mathilde
Hollebecque, Antoine https://orcid.org/0000-0003-2869-7551
Turpin, Anthony
Mazard, Thibault
Pernot, Simon https://orcid.org/0000-0003-4580-585X
Dutherage, Marie
Cohen, Romain
Borg, Christophe
Hautefeuille, Vincent https://orcid.org/0000-0003-2735-6448
Sclafani, Francesco
Ben-Abdelghani, Meher
Aparicio, Thomas https://orcid.org/0000-0001-8834-6927
De La Fouchardière, Christelle
Herve, Camille
Perkins, Geraldine
Heinrich, Kathrin
Kunzmann, Volker
Gallois, Claire
Guimbaud, Rosine
Tougeron, David https://orcid.org/0000-0002-8065-9635
Taieb, Julien https://orcid.org/0000-0002-9955-4753
Article History
Received: 10 July 2023
Revised: 9 November 2023
Accepted: 24 November 2023
First Online: 15 December 2023
Competing interests
: TM has received honoraria as a speaker or in an advisory role from Servier, Pierre Fabre, Merck Serono, AAA, Sanofi, and research funding from Amgen; and travel grants from Pierre Fabre, Merck Serono, and Sanofi. RC has received honoraria from AstraZeneca, Bristol-Myers Squibb, MSD Oncology, Mylan Medical, Pierre Fabre, Servier, and travel/accommodation fees from Amgen, Bristol-Myers Squibb, Mylan Medical, and Servier. CB has received honoraria from Bayer, Pierre Fabre, and MSD and research grants from Bayer and Roche. FS has received honoraria for consultancy, advisory roles, or speeches from AMAL Therapeutics, Amgen, Bayer, BMS, Dragonfly Therapeutics, Merck, Nordic Pharma, Roche, and Servier, research funding (institute) from Amgen, Astra Zeneca, Bayer, BMS, Roche, and Sanofi, support for travel/accommodation from Amgen, Bayer, Lilly, and Servier, and serves as Co-Chair of the EORTC Task Force Colon, Rectum, Anal Canal. TA has received honoraria as a speaker or in an advisory role from Amgen, Servier, Pierre Fabre, BMS, SIRTEC, and MSD. CG has participated in consulting and/or advisory boards for Servier, Sanofi, Merck, and Pierre Fabre, and has received support for travel to meetings from Amgen and Pierre Fabre. DT has received honoraria as a speaker or in an advisory role from Sanofi, Roche, Merck Serono, Amgen, Servier, Pierre Fabre, BMS, Astra Zeneca, and MSD. JT has received honoraria as a speaker or in an advisory role from Sanofi, Roche, Merck Serono, Amgen, Servier, Pierre Fabre, Lilly, Astra Zeneca, and MSD. Other authors do not report any competing interest.
: This study was approved by the French Data Protection Authority (CNIL) (2222018v0) and by the APHP (Assistance Publique des Hopitaux de Paris) ethics and research committee. It complies with the Declaration of Helsinki and is registered on the Health Data Hub site No. F20210315164546 within the framework of the MR-004 methodology. An information memo was given to all centers to be sent to patients. No patient objected to the use of their data.